次世代シーケンサー市場規模、シェア、成長分析、オファリング別、タイプ別、技術別、ワークフロー別、エンドユーザー別、用途別、地域別-2025～2032年産業予測

次世代シーケンサーの世界市場規模は、2023年に117億米ドルと評価され、予測期間（2025～2032年）のCAGRは14.3%で、2024年の133億7,000万米ドルから2032年には389億6,000万米ドルに成長する展望です。

次世代シーケンス（NGS）は、ゲノム分析における革新的なアプローチであり、大規模な並列性を活用して数百万から数十億のDNA鎖の塩基配列を同時に決定することで、従来のサンガーシーケンスと比較して効率的かつ費用対効果の高いものとなっています。NGSの利点には、高い精度、迅速な結果、最小限のサンプル量から正確なデータを生成できることなどがあります。この技術は、バイオマーカー探索、がん研究、個別化医療、農業研究など、さまざまなセグメントで不可欠なものとなっています。特に、NGSはCOVID-19の感染と治療戦略を理解する上で重要な役割を果たしており、これはWelcome Sanger InstituteやNHSなどの機関のリソースを結集し、全ゲノムシーケンスを通じてウイルスの進化と拡散を分析しているCOVID-19 Genomics U.K. Consortium（COG-U.K.）の取り組みに代表されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• サプライチェーン分析
• 特許分析
• 技術分析
• 使用事例
• 顧客と購買基準の分析
• 貿易分析

次世代シーケンサー市場規模：オファリング別&CAGR（2025～2032年）

• 市場概要
• 製品
• サービス

次世代シーケンサー市場規模：タイプ別&CAGR（2025～2032年）

• 市場概要
• 消耗品
  • ライブラリー調製と試薬
  • シーケンスキットと試薬
  • その他
• プラットフォーム
  • シーケンスプラットフォーム
  • ライブラリ準備プラットフォーム
• バイオインフォマティクスツール
  • データ分析ソフトウェアとワークベンチ
  • データ視覚化ツール
  • その他のバイオインフォマティクスツール

次世代シーケンサー市場規模：技術別&CAGR（2025～2032年）

• 市場概要
• 合成によるシーケンス
• イオン半導体シーケンス
• スマートシーケンス
• ナノポアシーケンス
• その他のシーケンス技術

次世代シーケンサー市場規模：ワークフロー別&CAGR（2025～2032年）

• 市場概要
• シーケンス
• プレシーケンス
• データ分析

次世代シーケンサー市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 学術研究機関
• 製薬・バイオテクノロジー企業
• 臨床と診断ラボ
• その他

次世代シーケンサー市場規模：タイプ別&CAGR（2025～2032年）

• 市場概要
• シーケンスサービス
  • エクソームと対象リシーケンスとカスタムパネル
  • RNAシーケンス
  • DE Novoシーケンス
  • チップシーケンス
  • 全ゲノム配列分析
  • メチルシークエンシング
  • その他のシーケンスサービス
• プレシーケンスサービス
  • ライブラリの準備とターゲットの強化
  • サンプル調製
  • 品質管理
• バイオインフォマティクスとデータ分析サービス
  • データ分析
  • データの視覚化と解釈
  • データの保存と管理
• NGSプラットフォームサービス

次世代シーケンサー市場規模：ワークフロー別&CAGR（2025～2032年）

• 市場概要
• シーケンス
• プレシーケンスサービス
• データ分析サービス

次世代シーケンサー市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 学術研究機関
• 製薬・バイオテクノロジー企業
• 病院と臨床検査室
• その他

次世代シーケンサー市場規模：用途別&CAGR（2025～2032年）

• 市場概要
• 診断
  • がん診断
  • 感染症診断
  • 生殖健康診断
  • その他の診断用途
• 医薬品の発見と開発
  • 薬理ゲノミクス
  • その他の医薬品の発見と開発の用途
• 農業と動物調査
• その他

次世代シーケンサー市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

    主要企業プロファイル

    • Illumina Inc.（米国）
    • Thermo Fisher Scientific, Inc.（米国）
    • PerkinElmer Inc.（米国）
    • BGI Group（中国）
    • Agilent Technologies Inc.（米国）
    • Eurofins Scientific SE（ルクセンブルグ）
    • Pacific Biosciences of California Inc.（米国）
    • Oxford Nanopore Technologies（英国）
    • QIAGEN NV（オランダ）
    • F. Hoffmann-La Roche AG（スイス）
    • Psomagen, Inc.（韓国）
    • 10x Genomics Inc.（米国）

結論と提言

Global Next Generation Sequencing Market size was valued at USD 11.7 billion in 2023 and is poised to grow from USD 13.37 billion in 2024 to USD 38.96 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

Next-generation sequencing (NGS) represents a transformative approach in genomic analysis, leveraging massive parallelism to sequence millions to billions of DNA strands simultaneously, making it more efficient and cost-effective compared to traditional Sanger sequencing. NGS's advantages include high accuracy, rapid results, and the capability to generate precise data from minimal sample quantities. This technology has become essential in various fields, including biomarker discovery, cancer research, personalized medicine, and agricultural studies. Notably, NGS has played a critical role in understanding COVID-19 transmission and treatment strategies, exemplified by the efforts of the COVID-19 Genomics U.K. Consortium (COG-U.K.), which combines resources from institutions like the Welcome Sanger Institute and NHS to analyze the virus's evolution and spread through Whole-Genome Sequencing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next Generation Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next Generation Sequencing Market Segments Analysis

Global Next Generation Sequencing Market is segmented by Offering, Type, Technology, Workflow, End User, Application and region. Based on Offering, the market is segmented into Products and Services. Based on Type, the market is segmented into Sequencing Services, Presequencing Services, Bioinformatics & Data Analysis Services and NGS Platform Services. Based on Technology, the market is segmented into Sequencing By Synthesis, Ion Semiconductor Sequencing, Smrt Sequencing, Nanopore Sequencing and Other Sequencing Technologies. Based on Workflow, the market is segmented into Sequencing, Presequencing Services and Data Analysis Services. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories and Other End Users. Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next Generation Sequencing Market

The Global Next Generation Sequencing (NGS) market is significantly driven by its capability to thoroughly analyze an individual's genome, facilitating the detection of genetic variations. These variations play a crucial role in determining drug responses, disease susceptibility, and potential adverse effects. As a result, this personalized approach is increasingly leading to the integration of NGS in clinical environments, enhancing treatment outcomes by tailoring therapies to align with patients' unique genetic profiles. The ability to offer customized medical solutions not only improves effectiveness but also transforms the future of precision medicine, positioning NGS as a pivotal tool in modern healthcare.

Restraints in the Global Next Generation Sequencing Market

The high costs associated with next-generation sequencing (NGS) procedures, which include sequencing, data analysis, and interpretation, present significant challenges in accessibility for both patients and healthcare providers. The financial burden of purchasing and maintaining NGS technologies limits their application in clinical environments, especially within resource-limited settings. This financial constraint hampers the widespread adoption of NGS, preventing many medical professionals from integrating these advanced sequencing technologies into routine practice. Consequently, the limitations imposed by cost can inhibit advancements in personalized medicine and patient care, underscoring the need for solutions to lower barriers to entry for NGS applications.

Market Trends of the Global Next Generation Sequencing Market

The Global Next Generation Sequencing (NGS) market is experiencing significant growth, driven by its transformative role in diagnosing rare genetic disorders with unparalleled accuracy and speed. As healthcare providers increasingly adopt NGS technologies to sequence genomes, the market is witnessing heightened demand for personalized medicine, early intervention, and optimized management strategies for rare diseases. This trend is further fueled by advancements in NGS platforms, decreasing costs, and enhanced data analysis capabilities, positioning NGS as an indispensable tool in modern genomics and precision healthcare. Consequently, the NGS market is projected to expand robustly, reflecting its critical impact on patient outcomes and healthcare innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Supply Chain Analysis
• Patent Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Trade Analysis

Global Next Generation Sequencing Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Products
• Services

Global Next Generation Sequencing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Consumables
  • Library Preparation & And Reagents
  • Sequencing Kits & Reagents
  • Other Consumables
• Platforms
  • Sequencing Platforms
  • Library Preparation Platforms
• Bioinformatics Tools
  • Data Analysis Software & Workbenches
  • Data Visualization Tools
  • Other Bioinformatics Tools

Global Next Generation Sequencing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Smrt Sequencing
• Nanopore Sequencing
• Other Sequencing Technologies

Global Next Generation Sequencing Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sequencing
• Presequencing
• Data Analysis

Global Next Generation Sequencing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical & Diagnostic Laboratories
• Other End Users

Global Next Generation Sequencing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Sequencing Services
  • Exome & Targeted Resequencing and Custom Panels
  • RNA Sequencing
  • DE Novo Sequencing
  • Chip Sequencing
  • Whole-Genome Sequencing
  • Methyl Sequencing
  • Other Sequencing Services
• Presequencing Services
  • Library Preparation & Target Enrichment
  • Sample Preparation
  • Quality Control
• Bioinformatics & Data Analysis Services
  • Data Analysis
  • Data Visualization & Interpretation
  • Data Storage & Management
• NGS Platform Services

Global Next Generation Sequencing Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sequencing
• Presequencing Services
• Data Analysis Services

Global Next Generation Sequencing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Laboratories
• Other End Users

Global Next Generation Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • Reproductive Health Diagnostics
  • Other Diagnostic Applications
• Drug Discovery & Development
  • Pharmacogenomics
  • Other Drug Discovery & Development Applications
• Agriculture & Animal Research
• Other Applications

Global Next Generation Sequencing Market Size & CAGR (2025-2032)

• North America (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
  • US
  • Canada
• Europe (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Type, Technology, Workflow, End User, Type, Workflow, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations